We identified 205 gBRCA1/2 PV carriers with newly diagnosed, HER2-negative early breast cancer, including 113 with HR+ and 92 with TNBC (Fig. 1, Supplementary Table 1). The gene discussed is ERBB2; the disease is breast cancer.